敗血症の世界市場レポート 2025年

敗血症市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.0％で14億4,000万米ドルに成長します。予測期間の成長は、クリティカルケアにおける人工知能の採用の増加、多剤耐性感染症の蔓延、敗血症に関する啓蒙活動の拡大、新興国におけるヘルスケアインフラの拡大、バイオテクノロジーや製薬研究に対する投資の増加などに起因すると考えられます。予測期間における主な動向としては、迅速なポイントオブケア診断の開発、AIを活用した予測分析の導入、個別化された抗生物質スチュワードシップ・プログラム、血液培養技術の進歩、革新的なバイオマーカーの同定、免疫調節を標的とした新規治療法の開発などが挙げられます。

感染症の蔓延の拡大は、今後数年間の敗血症市場の拡大を促進すると予想されます。感染症は、細菌、ウイルス、真菌、または寄生虫によって引き起こされ、直接接触、汚染源、または昆虫媒介によって広がる可能性があります。一般的な例としては、結核、インフルエンザ、白癬、マラリアなどが挙げられます。感染症の罹患率の増加には、世界化、環境の変化、薬剤耐性病原体、ヘルスケアシステムの格差など、いくつかの要因が関与しています。感染症の深刻な合併症である敗血症は、身体の極端な反応から生じ、広範囲に炎症を引き起こし、臓器不全に陥る可能性があります。例えば、2024年11月、米国疾病管理予防センターは、2023年に米国で9,633件の結核患者が報告され、2022年に報告された8,332件から15.6％増加したと報告しました。その結果、感染症の負担増が敗血症市場の成長に拍車をかけています。

敗血症市場の企業は、人工知能（AI）を搭載したプラットフォームなどの先進技術を活用して、早期診断の改善、治療精度の向上、患者の転帰予測を行っています。これらのイノベーションは、敗血症の管理における死亡率の低下とヘルスケア効率の向上を目指しています。例えば2024年6月、米国のヘルスケア企業Predicate Healthcare Performance Group（HPG）は、敗血症の早期兆候を検出するウェアラブルバイオセンサーを統合したAI搭載診断プラットフォームOpenDXを発表しました。この技術は敗血症の診断を助け、他の病状にも応用できる可能性があり、診断におけるAIの役割が増大していることを強調しています。Predicateの胸部センサーにより、医療専門家は診断が困難なことが多い敗血症の初期指標を特定することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界敗血症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の敗血症市場：成長率分析
• 世界の敗血症市場の実績：規模と成長, 2019-2024
• 世界の敗血症市場の予測：規模と成長, 2024-2029, 2034F
• 世界敗血症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の敗血症市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 治療薬
• 世界の敗血症市場病原体別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌性
• バイラル
• 真菌
• 世界の敗血症市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 重度の敗血症
• 敗血症性ショック
• 世界の敗血症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 病理学
• リファレンスラボ
• 世界の敗血症市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 画像技術
• 微生物学的培養検査
• バイオマーカー検査
• その他の診断方法
• 世界の敗血症市場、治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 抗真菌剤
• 血管収縮薬
• 免疫グロブリン
• コルチコステロイド
• その他の治療オプション

第7章 地域別・国別分析

• 世界の敗血症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の敗血症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 敗血症市場：競合情勢
• 敗血症市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott laboratories
• Novartis AG
• Siemens AG
• Asahi Kasei Corporation
• Becton, Dickinson and Company
• bioMerieux SA
• QuidelOrtho Corporation
• Diasorin S.p.A.
• Innoviva Inc.
• Seegene Inc.
• EKF Diagnostics
• Boditech Med Inc.
• Cytovale Inc.
• Alifax S.r.l.
• Hansa Biopharma

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 敗血症市場2029：新たな機会を提供する国
• 敗血症市場2029：新たな機会を提供するセグメント
• 敗血症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sepsis is a life-threatening condition resulting from the body's extreme response to an infection. It occurs when the immune system releases chemicals into the bloodstream to combat the infection, but these chemicals trigger widespread inflammation, leading to tissue damage, organ failure, and potentially death.

The primary aspects of sepsis management include diagnosis and therapeutics. Diagnosis focuses on detecting sepsis through various tests and procedures that identify infections and assess their severity. The condition can be caused by pathogens such as bacteria, viruses, and fungi. Sepsis-related applications include severe sepsis and septic shock, with utilization in hospitals, pathology labs, and reference laboratories.

The sepsis market research report is one of a series of new reports from The Business Research Company that provides sepsis market statistics, including the sepsis industry's global market size, regional shares, competitors with a sepsis market share, detailed sepsis market segments, market trends and opportunities, and any further data you may need to thrive in the sepsis industry. This sepsis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the increasing incidence of sepsis due to aging populations, the rising prevalence of chronic diseases, greater awareness of sepsis among healthcare providers, escalating healthcare expenditures, and the implementation of government initiatives for early detection and management.

The sepsis market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the increasing adoption of artificial intelligence in critical care, the rising prevalence of multidrug-resistant infections, growing awareness campaigns about sepsis, expanding healthcare infrastructure in emerging economies, and increasing investments in biotechnology and pharmaceutical research. Major trends in the forecast period include the development of rapid point-of-care diagnostics, the adoption of AI-driven predictive analytics, personalized antibiotic stewardship programs, advancements in blood culture techniques, innovative biomarker identification, and the development of novel therapies targeting immune modulation.

The growing prevalence of infectious diseases is expected to drive the expansion of the sepsis market in the coming years. Infectious diseases, caused by bacteria, viruses, fungi, or parasites, can spread through direct contact, contaminated sources, or insect vectors. Common examples include tuberculosis, influenza, ringworm, and malaria. Several factors contribute to the increasing incidence of infectious diseases, including globalization, environmental changes, drug-resistant pathogens, and gaps in healthcare systems. Sepsis, a severe complication of infections, results from the body's extreme response, leading to widespread inflammation and potential organ failure. For example, in November 2024, the Centers for Disease Control and Prevention reported that the United States recorded 9,633 cases of tuberculosis (TB) in 2023, marking a 15.6% increase from the 8,332 cases reported in 2022. Consequently, the rising burden of infectious diseases is fueling the growth of the sepsis market.

Companies in the sepsis market are leveraging advanced technology, such as artificial intelligence (AI)-powered platforms, to improve early diagnosis, enhance treatment precision, and predict patient outcomes. These innovations aim to reduce mortality rates and enhance healthcare efficiency in managing sepsis. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched OpenDX, an AI-powered diagnostic platform integrating wearable biosensors to detect early signs of sepsis. This technology aids in sepsis diagnosis and has the potential for application in other medical conditions, highlighting the increasing role of AI in diagnostics. Predicate's chest sensor enables healthcare professionals to identify early indicators of sepsis, a condition that is often challenging to diagnose.

In April 2024, Prenosis Inc., a US-based biotechnology research company, partnered with Roche Holding AG to advance sepsis diagnosis and management through AI-driven technology. As part of the partnership, Roche will distribute Prenosis' Sepsis ImmunoScore, an AI-based medical software designed to assist healthcare providers in rapidly diagnosing sepsis and predicting adverse outcomes. This collaboration enhances clinical sepsis management by integrating AI technology into healthcare settings. Roche Holding AG is a Switzerland-based pharmaceutical company specializing in oncology, immunology, infectious diseases, and other medical fields.

Major players in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMerieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.

North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis market includes revenues earned by entities by providing services such as blood culture testing, molecular diagnostics, biomarker testing, intravenous (IV) fluid management, organ support services, and tele-ICU services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnosis; Therapeutics
• 2) By Pathogen: Bacterial; Viral; Fungal
• 3) By Application: Severe Sepsis; Septic Shock
• 4) By End User: Hospitals; Pathology; Reference Laboratories
• Subsegments:
• 1) By Diagnosis: Blood Tests; Imaging Techniques; Microbiological Culture Tests; Biomarker Tests; Other Diagnostic Methods
• 2) By Therapeutics: Antibiotics; Antifungal Agents; Vasopressors; Immunoglobulins; Corticosteroids; Other Therapeutic Options
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck KGaA; Bayer AG; Thermo Fisher Scientific Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sepsis Market Characteristics

3. Sepsis Market Trends And Strategies

4. Sepsis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Sepsis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sepsis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sepsis Market Growth Rate Analysis
• 5.4. Global Sepsis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sepsis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sepsis Total Addressable Market (TAM)

6. Sepsis Market Segmentation

• 6.1. Global Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Therapeutics
• 6.2. Global Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial
• Viral
• Fungal
• 6.3. Global Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Severe Sepsis
• Septic Shock
• 6.4. Global Sepsis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Pathology
• Reference Laboratories
• 6.5. Global Sepsis Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Imaging Techniques
• Microbiological Culture Tests
• Biomarker Tests
• Other Diagnostic Methods
• 6.6. Global Sepsis Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antifungal Agents
• Vasopressors
• Immunoglobulins
• Corticosteroids
• Other Therapeutic Options

7. Sepsis Market Regional And Country Analysis

• 7.1. Global Sepsis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sepsis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sepsis Market

• 8.1. Asia-Pacific Sepsis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sepsis Market

• 9.1. China Sepsis Market Overview
• 9.2. China Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sepsis Market

• 10.1. India Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sepsis Market

• 11.1. Japan Sepsis Market Overview
• 11.2. Japan Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sepsis Market

• 12.1. Australia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sepsis Market

• 13.1. Indonesia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sepsis Market

• 14.1. South Korea Sepsis Market Overview
• 14.2. South Korea Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sepsis Market

• 15.1. Western Europe Sepsis Market Overview
• 15.2. Western Europe Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sepsis Market

• 16.1. UK Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sepsis Market

• 17.1. Germany Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sepsis Market

• 18.1. France Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sepsis Market

• 19.1. Italy Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sepsis Market

• 20.1. Spain Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sepsis Market

• 21.1. Eastern Europe Sepsis Market Overview
• 21.2. Eastern Europe Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sepsis Market

• 22.1. Russia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sepsis Market

• 23.1. North America Sepsis Market Overview
• 23.2. North America Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sepsis Market

• 24.1. USA Sepsis Market Overview
• 24.2. USA Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sepsis Market

• 25.1. Canada Sepsis Market Overview
• 25.2. Canada Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sepsis Market

• 26.1. South America Sepsis Market Overview
• 26.2. South America Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sepsis Market

• 27.1. Brazil Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sepsis Market

• 28.1. Middle East Sepsis Market Overview
• 28.2. Middle East Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sepsis Market

• 29.1. Africa Sepsis Market Overview
• 29.2. Africa Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sepsis Market Competitive Landscape And Company Profiles

• 30.1. Sepsis Market Competitive Landscape
• 30.2. Sepsis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sepsis Market Other Major And Innovative Companies

• 31.1. Abbott laboratories
• 31.2. Novartis AG
• 31.3. Siemens AG
• 31.4. Asahi Kasei Corporation
• 31.5. Becton, Dickinson and Company
• 31.6. bioMerieux SA
• 31.7. QuidelOrtho Corporation
• 31.8. Diasorin S.p.A.
• 31.9. Innoviva Inc.
• 31.10. Seegene Inc.
• 31.11. EKF Diagnostics
• 31.12. Boditech Med Inc.
• 31.13. Cytovale Inc.
• 31.14. Alifax S.r.l.
• 31.15. Hansa Biopharma

32. Global Sepsis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sepsis Market

34. Recent Developments In The Sepsis Market

35. Sepsis Market High Potential Countries, Segments and Strategies

• 35.1 Sepsis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sepsis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sepsis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer